Comprehensive review of Wernicke encephalopathy: pathophysiology, clinical symptoms and imaging findings.


Journal

Japanese journal of radiology
ISSN: 1867-108X
Titre abrégé: Jpn J Radiol
Pays: Japan
ID NLM: 101490689

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 09 04 2020
accepted: 29 04 2020
pubmed: 12 5 2020
medline: 11 3 2021
entrez: 12 5 2020
Statut: ppublish

Résumé

Wernicke's encephalopathy (WE) is a severe and life-threatening illness resulting from vitamin B1 (thiamine) deficiency. The prevalence of WE has been estimated from 0.4 to 2.8%. If not treated properly, severe neurologic disorders such as Korsakoff psychosis and even death may occur. The classical triad of clinical symptoms (abnormal mental state, ataxia, and ophthalmoplegia) is found in only 16-33% of patients on initial examination. The originally described underlying condition of WE is alcoholism, but it accounts for about 50% of causes of WE. Nonalcoholic patients are also affected by WE and likely to present symptoms and radiological imaging findings different from patients with alcoholism, which further complicates the diagnosis of WE. Being familiar with predisposing causes, symptoms and radiological imaging findings of WE is important for radiologists and clinicians when making the diagnosis to start immediate treatment. This review discusses pathophysiologies, underlying causes, clinical symptoms, imaging findings and their mimics.

Identifiants

pubmed: 32390125
doi: 10.1007/s11604-020-00989-3
pii: 10.1007/s11604-020-00989-3
doi:

Substances chimiques

Thiamine X66NSO3N35

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

809-820

Références

Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J. 2014;44(9):911–5.
doi: 10.1111/imj.12522
Lough ME. Wernicke's encephalopathy: expanding the diagnostic toolbox. Neuropsychol Rev. 2012;22(2):181–94. https://doi.org/10.1007/s11065-012-9200-7 .
doi: 10.1007/s11065-012-9200-7 pubmed: 22577001
Galvin R, Brathen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17(12):1408–18. https://doi.org/10.1111/j.1468-1331.2010.03153.x .
doi: 10.1111/j.1468-1331.2010.03153.x pubmed: 20642790
Ogershok PR, Rahman A, Nestor S, Brick J. Wernicke encephalopathy in nonalcoholic patients. Am J Med Sci. 2002;323(2):107–11.
doi: 10.1097/00000441-200202000-00010
Chandrakumar A, Bhardwaj A, Jong GW. Review of thiamine deficiency disorders: Wernicke encephalopathy and Korsakoff psychosis. J Basic Clin Physiol Pharmacol. 2018;30(2):153–62. https://doi.org/10.1515/jbcpp-2018-0075 .
doi: 10.1515/jbcpp-2018-0075 pubmed: 30281514
Manzo G, De Gennaro A, Cozzolino A, Serino A, Fenza G, Manto A. MR imaging findings in alcoholic and nonalcoholic acute Wernicke's encephalopathy: a review. Biomed Res Int. 2014;2014:503596. https://doi.org/10.1155/2014/503596 .
doi: 10.1155/2014/503596 pubmed: 25050351 pmcid: 4094710
Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007;6(5):442–55.
doi: 10.1016/S1474-4422(07)70104-7
Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke's encephalopathy: review of the literature. AJR Am J Roentgenol. 2009;192(2):501–8. https://doi.org/10.2214/AJR.07.3959 .
doi: 10.2214/AJR.07.3959 pubmed: 19155417
Zuccoli G, Santa Cruz D, Bertolini M, Rovira A, Gallucci M, Carollo C, et al. MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol. 2009;30(1):171–6. https://doi.org/10.3174/ajnr.A1280 .
doi: 10.3174/ajnr.A1280 pubmed: 18945789 pmcid: 7051709
Jung YC, Chanraud S, Sullivan EV. Neuroimaging of Wernicke's encephalopathy and Korsakoff's syndrome. Neuropsychol Rev. 2012;22(2):170–80. https://doi.org/10.1007/s11065-012-9203-4 .
doi: 10.1007/s11065-012-9203-4 pubmed: 22577003 pmcid: 4728174
Stokum JA, Kurland DB, Gerzanich V, Simard JM. Mechanisms of astrocyte-mediated cerebral edema. Neurochem Res. 2015;40(2):317–28. https://doi.org/10.1007/s11064-014-1374-3 .
doi: 10.1007/s11064-014-1374-3 pubmed: 24996934
Cabezas R, Avila M, Gonzalez J, El-Bachá RS, Báez E, García-Segura LM, et al. Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease. Front Cell Neurosci. 2014;8:211.
doi: 10.3389/fncel.2014.00211
Thrane AS, Rangroo Thrane V, Nedergaard M. Drowning stars: reassessing the role of astrocytes in brain edema. Trends Neurosci. 2014;37(11):620–8. https://doi.org/10.1016/j.tins.2014.08.010 .
doi: 10.1016/j.tins.2014.08.010 pubmed: 25236348 pmcid: 4253572
Thomson AD, Cook CC, Guerrini I, Sheedy D, Harper C, Marshall EJ. Wernicke's encephalopathy revisited: translation of the case history section of the original manuscript by Carl Wernicke 'Lehrbuch der Gehirnkrankheiten fur Aerzte and Studirende' (1881) with a commentary. Alcohol. 2008;43(2):174–9.
doi: 10.1093/alcalc/agm144
Sinha S, Kataria A, Kolla BP, Thusius N, Loukianova LL. Wernicke encephalopathy-clinical pearls. Mayo Clin Proc. 2019;94(6):1065–72. https://doi.org/10.1016/j.mayocp.2019.02.018 .
doi: 10.1016/j.mayocp.2019.02.018 pubmed: 31171116
Chamorro AJ, Rosón-Hernández B, Medina-García JA, Muga-Bustamante R, Fernández-Solá J, Martín-González MC, et al. Differences between alcoholic and nonalcoholic patients with wernicke encephalopathy: a multicenter observational study. Mayo Clin Proc. 2017;92(6):899–907. https://doi.org/10.1016/j.mayocp.2017.02.019 .
doi: 10.1016/j.mayocp.2017.02.019 pubmed: 28578781
Fei GQ, Zhong C, Jin L, Wang J, Zhang Y, Zheng X, et al. Clinical characteristics and MR imaging features of nonalcoholic wernicke encephalopathy. AJNR Am J Neuroradiol. 2008;29(1):164–9. https://doi.org/10.3174/ajnr.A0827 .
doi: 10.3174/ajnr.A0827 pubmed: 18192344 pmcid: 8119112
Martin PR, Singleton CK, Hiller-Sturmhöfel S. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health. 2003;27(2):134–42.
pubmed: 15303623 pmcid: 6668887
Oudman E, Wijnia JW, Oey M, van Dam M, Painter RC, Postma A. Wernicke's encephalopathy in hyperemesis gravidarum: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2019;236:84–93. https://doi.org/10.1016/j.ejogrb.2019.03.006 .
doi: 10.1016/j.ejogrb.2019.03.006 pubmed: 30889425
Kotha VK, De Souza A. Wernicke's encephalopathy following Hyperemesis gravidarum: a report of three cases. Neuroradiol J. 2013;26(1):35–40.
doi: 10.1177/197140091302600106
Buesa JM, García-Teijido P, Losa R, Fra J. Treatment of ifosfamide encephalopathy with intravenous thiamin. Clin Cancer Res. 2003;9(12):4636–7.
pubmed: 14555540
Sechi G, Batzu L, Agrò L, Fois C. Cancer-related Wernicke-Korsakoff syndrome. Lancet Oncol. 2016;17(6):e221–e22222. https://doi.org/10.1016/S1470-2045(16)30109-7 .
doi: 10.1016/S1470-2045(16)30109-7 pubmed: 27299273
Cho IJ, Chang HJ, Lee KE, Won HS, Choi MY, Nam EM, et al. A case of Wernicke's encephalopathy following fluorouracil-based chemotherapy. J Korean Med Sci. 2009;24(4):747–50. https://doi.org/10.3346/jkms.2009.24.4.747 .
doi: 10.3346/jkms.2009.24.4.747 pubmed: 19654964 pmcid: 2719188
Zuccoli G, Motti L. Atypical Wernicke's encephalopathy showing lesions in the cranial nerve nuclei and erebellum. J Neuroimaging. 2008;18(2):194–7. https://doi.org/10.1111/j.1552-6569.2007.00188.x .
doi: 10.1111/j.1552-6569.2007.00188.x pubmed: 18298680
Bonucchi J, Hassan I, Policeni B, Kaboli P. Thyrotoxicosis associated Wernicke's encephalopathy. J Gen Intern Med. 2008;23(1):106–9.
doi: 10.1007/s11606-007-0438-3
Wijnia JW, Oudman E, van Gool WA, Wierdsma AI, Bresser EL, Bakker J, et al. Severe infections are common in thiamine deficiency and may be related to cognitive outcomes: a cohort study of 68 patients with Wernicke-Korsakoff syndrome. Psychosomatics. 2016;57(6):624–33. https://doi.org/10.1016/j.psym.2016.06.004 .
doi: 10.1016/j.psym.2016.06.004 pubmed: 27498674
Donnino MW, Carney E, Cocchi MN, Barbash I, Chase M, Joyce N, et al. Thiamine deficiency in critically ill patients with sepsis. J Crit Care. 2010;25(4):576–81. https://doi.org/10.1016/j.jcrc.2010.03.003 .
doi: 10.1016/j.jcrc.2010.03.003 pubmed: 20646908
Yamada K, Miura K, Hara K, Suzuki M, Nakanishi K, Kumagai T, et al. A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations. BMC Med Genet. 2010;11:171. https://doi.org/10.1186/1471-2350-11-171 .
doi: 10.1186/1471-2350-11-171 pubmed: 21176162 pmcid: 3022826
Alfadhel M, Almuntashri M, Jadah RH, Bashiri FA, Al Rifai MT, Al Shalaan H, et al. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases. Orphanet J Rare Dis. 2013;8:83. https://doi.org/10.1186/1750-1172-8-83 .
doi: 10.1186/1750-1172-8-83 pubmed: 23742248 pmcid: 3691666
Ashikaga R, Araki Y, Ono Y, Itami N, Akamatsu M, Kinoshita K. FLAIR appearance of Wernicke encephalopathy. Radiat Med. 1997;15(4):251–3.
pubmed: 9311044
Maeda M, Tsuchida C, Handa Y, Ishii Y. Fluid attenuated inversion recovery (FLAIR) imaging in acute Wernicke encephalopathy. Radiat Med. 1995;13(6):311–3.
pubmed: 8850375
Halavaara J, Brander A, Lyytinen J, Setälä K, Kallela M. Wernicke's encephalopathy: is diffusion-weighted MRI useful? Neuroradiology. 2003;45(8):519–23.
doi: 10.1007/s00234-003-1043-8
Mascalchi M, Simonelli P, Tessa C, Giangaspero F, Petruzzi P, Bosincu L, et al. Do acute lesions of Wernicke's encephalopathy show contrast enhancement? Report of three cases and review of the literature. Neuroradiology. 1999;41(4):249–54.
doi: 10.1007/s002340050741
Zuccoli G, Gallucci M, Capellades J, Regnicolo L, Tumiati B, Giadás TC, et al. Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients. AJNR Am J Neuroradiol. 2007;28(7):1328–31.
doi: 10.3174/ajnr.A0544
Murata T, Fujito T, Kimura H, Omori M, Itoh H, Wada Y. Serial MRI and (1)H-MRS of Wernicke's encephalopathy: report of a case with remarkable cerebellar lesions on MRI. Psychiatry Res. 2001;108(1):49–55.
doi: 10.1016/S0925-4927(01)00304-3
Pfefferbaum A, Adalsteinsson E, Bell RL, Sullivan EV. Development and resolution of brain lesions caused by pyrithiamine- and dietary-induced thiamine deficiency and alcohol exposure in the alcohol-preferring rat: a longitudinal magnetic resonance imaging and spectroscopy study. Neuropsychopharmacology. 2007;32(5):1159–77.
doi: 10.1038/sj.npp.1301107
Weidauer S, Nichtweiss M, Lanfermann H, Zanella FE. Wernicke encephalopathy: MR findings and clinical presentation. Eur Radiol. 2003;13(5):1001–9.
doi: 10.1007/s00330-002-1624-7
Pandey D, Kuhn JL, Tejero H, Banks JS. Alcohol induced wernicke encephalopathy with atypical MRI findings. Cureus. 2019;11(7):e5203. https://doi.org/10.7759/cureus.5203 .
doi: 10.7759/cureus.5203 pubmed: 31565609 pmcid: 6758985
Opdenakker G, Gelin G, De Surgeloose D, Palmers Y. Wernicke encephalopathy: MR findings in two patients. Eur Radiol. 1999;9(8):1620–4.
doi: 10.1007/s003300050896
Zhong C, Jin L, Fei G. MR Imaging of nonalcoholic Wernicke encephalopathy: a follow-up study. AJNR Am J Neuroradiol. 2005;26(9):2301–5.
pubmed: 16219836 pmcid: 7976163
Kornreich L, Bron-Harlev E, Hoffmann C, Schwarz M, Konen O, Schoenfeld T, et al. Thiamine deficiency in infants: MR findings in the brain. AJNR Am J Neuroradiol. 2005;26(7):1668–744.
pubmed: 16091511 pmcid: 7975150
Zuccoli G, Siddiqui N, Bailey A, Bartoletti SC. Neuroimaging findings in pediatric Wernicke encephalopathy: a review. Neuroradiology. 2010;52(6):523–9. https://doi.org/10.1007/s00234-009-0604-x .
doi: 10.1007/s00234-009-0604-x pubmed: 19844698
Rovira A, Alonso J, Córdoba J. MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol. 2008;29(9):1612–21. https://doi.org/10.3174/ajnr.A1139 .
doi: 10.3174/ajnr.A1139 pubmed: 18583413 pmcid: 8118773
McKinney AM, Lohman BD, Sarikaya B, Uhlmann E, Spanbauer J, Singewald T, et al. Acute hepatic encephalopathy: diffusion-weighted and fluid-attenuated inversion recoveryfindings, and correlation with plasma ammonia level and clinical outcome. AJNR Am J Neuroradiol. 2010;31(8):1471–9. https://doi.org/10.3174/ajnr.A2112 .
doi: 10.3174/ajnr.A2112 pubmed: 20448015 pmcid: 7966093
Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004;75(3):22–8.
Zuccoli G, Siddiqui N, Cravo I, Bailey A, Gallucci M, Harper CG. Neuroimaging findings in alcohol-related encephalopathies. AJR Am J Roentgenol. 2010;195(6):1378–84. https://doi.org/10.2214/AJR.09.4130 .
doi: 10.2214/AJR.09.4130 pubmed: 21098198
McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol. 2007;189(4):904–12.
doi: 10.2214/AJR.07.2024

Auteurs

Yoshiaki Ota (Y)

The Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI, 48109, USA. ootayoshiaki@gmail.com.
Department of Radiology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, 465 Kajii-cho, Kyoto, Kyoto, 602-8566, Japan. ootayoshiaki@gmail.com.

Aristides A Capizzano (AA)

The Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI, 48109, USA.

Toshio Moritani (T)

The Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI, 48109, USA.

Shotaro Naganawa (S)

The Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI, 48109, USA.

Ryo Kurokawa (R)

Department of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Ashok Srinivasan (A)

The Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI, 48109, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH